PFE has both vaccine and pill treatment, so I do not see why it would not stay above prior resistance of mid-40's, which it became support not too long ago. Given the high float and increased profit-taking, I'd say low 50's to high 50's in the near-term is a VERY conservative target. If the COVID pill approval follows the above timeline successfully, it should go beyond 50's into the 60's at least by the next earning season as that earning should include the early orders for the COVID pills. It appears that the expectation is not well priced in for the upward movement for this ticker, but we shall see if that'd be the same story.

Of course, this is all based on the approval of the COVID pill, which I don't see why it wouldn't. This is not financial advice. I do own some call options.

 $Pfizer(PFE)$